ReviewJournal of cancer research and clinical oncology2023

Efficacy and safety of transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors in the treatment of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Junning Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.